Accurate assessment of inspiratory muscle strength in patients is of value in the inBackground -Inspiratory muscle weakvestigation of dyspnoea unexplained by cardiac ness is a recognised cause of unexplained or respiratory disease. 1 Although measurement dyspnoea. It may be suggested by the findof maximum static inspiratory mouth pressure ing of a low static inspiratory mouth pres-(MIP) is a simple and commonly applied test, sure (MIP), but MIP is a difficult test to the normal range is wide even in experienced perform, with a wide normal range; a low subjects. 2 3 Thus, although attainment of a high MIP may also occur if the patient has MIP probably excludes significant inspiratory not properly performed the manoeuvre. muscle weakness, patients frequently generate Further investigation conventionally relow values which fail to differentiate between quires balloon catheters to obtain oesogenuine mild weakness or difficulty with the phageal (Poes) and transdiaphragmatic technique. Moreover, the MIP does not dispressure (Pdi) during sniffs or phrenic criminate specific diaphragm weakness. For nerve stimulation. Two non-invasive tests these patients it is usual to obtain a more of inspiratory muscle strength have re-accurate assessment of inspiratory muscle cently been described -nasal pressure strength by measuring pleural and transduring a maximal sniff (Sn Pnas) and diaphragmatic pressure during a sniff 4 5 and mouth pressure during magnetic stimu-during phrenic nerve stimulation.
Patients with contraindications to magnetic simultaneous visual feedback from a monitor.
Manoeuvres were separated by at least 30 secnerve stimulation -that is, the presence of a cardiac pacemaker or cerebral aneurysm clips onds rest and continued until no further increase in pressure could be obtained. -were excluded from the study. Patients with potential swallowing difficulty such as motor Sniffs were performed with the subject seated at functional residual capacity (FRC). Simneurone disease were carefully assessed prior to passing the balloons.
ilarly, the monitor screen was visible to the subject and sniffs were recorded until no further increase in pressures could be obtained.
5
Phrenic nerve stimulation was performed  Mouth pressures were measured using a seated at FRC with the neck flexed using a Magstim 200 HP stimulator (Magstim Co, flanged mouthpiece attached to a brass tube incorporating a valve and 2mm leak to prevent Whitland, Dyfed, UK) with a circular 90mm coil positioned dorsally over the cervical spine. 13 glottic closure. Oesophageal (Poes) and transdiaphragmatic pressures (Pdi) were measured Subjects rested for 20 minutes before stimulation to minimise twitch potentiation. 14 To from latex balloons mounted on 100 cm polythene catheters passed pernasally and po-obtain Tw Pmo an automatic triggering mechanism was used. 9 While the subject breathed sitioned in the oesophagus and stomach. Pressure at the nose (Pnas) was measured via quietly through the mouthpiece and tube the operator positioned the stimulator coil on the an 80cm catheter held in the nostril by a soft, hand fashioned nasal plug (Optosil P, Bayer, neck. After relaxing at FRC the valve was closed and the subject was then asked to exhale gently. Leverkusen, Germany). The MIP was defined as the greatest (most intosh Centris computer (Apple Computers, Cupertino, California, USA) running LabView negative) value that could be sustained for one second; the best effort was selected for analysis. software (National Instruments) and sampling at 100Hz. The signals were neither filtered nor Sniffs were only accepted if the trace showed a rapid upstroke to a sharp peak. The greatest smoothed. The transducers were shown to be linear over the range of pressures measured in value obtained after instruction and with verbal encouragement was selected for analysis. Since this study and the frequency response of the balloon and catheter-transducer system, de-in clinical practice Sn Pnas would be performed without an oesophageal balloon and the relation termined by a pop test, was approximately 14Hz.
to FRC would be unknown, the baseline for Sn Poes and Sn Pnas was determined as the pressure at end-expiration immediately before  MIP was measured from residual volume while the onset of the sniff upstroke, and the amplitude was the difference between this level and seated and wearing a nose clip.
12 Maximum inspiratory effort was encouraged verbally with the nadir. For twitch Pdi, traces were accepted for analysis if the subject was at FRC. For Tw Pmo, Figure 1 (A Figure 2 shows ROC curves for Sn Pnas and Tw Pmo when used individually and in the 17 patients, in two the Sn Pnas was above the limit value, and in eight Tw Pmo exceeded combination. The effect of applying differing cut off values on the sensitivity and false positive the limit value. Thus, in 15 of the 17 subjects (88%) with a low MIP normal strength could rate (defined as 1 -specificity) for confirming group.bmj.com on June 20, 2017 -Published by http://thorax.bmj.com/ Downloaded from testing was based on values previously reported in the literature from our laboratories. 4-6 15 For the non-invasive tests we chose values slightly higher than those previously reported 9 16 17 ; the rationale for this was that we wanted to set a level which would allow us confidently to avoid placement of balloon catheters. Our cut off values were based on the principle of detecting the greatest proportion of subjects who are truly strong, while keeping as small as possible the possibility of falsely declaring normal strength as this implies failure to detect weak respiratory muscles. The ROC plots show that our selected cut off points achieved this aim, although slightly lower values would have achieved similar results. Equally, specific cut off values for each sex (or, indeed, age group) might refine the determination of strength by Sn Pnas and Tw Pmo, but our patient numbers are insufficient for meaningful analysis in this regard. Indeed, the two false negative cases were both men, suggesting that, in our data at least, reduced cut off values for women are unnecessary.
The clinical application of Sn Pnas and Tw Pmo assumes that pressure is well transmitted from the pleura to the mouth. This may be a particular problem in chronic obstructive pulmonary disease (COPD) during phrenic nerve stimulation 18 and, to a lesser extent, during sniffs. 19 In COPD this is compounded by the altered geometry of the diaphragm which causes a disproportionate reduction in the capacity of the diaphragm to lower intrathoracic (and hence mouth) pressure 20 and is demonstrated by patient no. 1. Although Sn Pnas and Tw Pmo may falsely suggest weakness if used in patients with severe airflow obstruction, this does not alter our conclusion that inspiratory muscle weakness may be excluded if the cut off values are achieved with these tests. A protocol for suspected respiratory muscle weakness using mouth pressure measurements followed by Sn Pnas and Tw Pmo and finally but more complex and demanding at each level. An alternative strategy whereby Sn Pnas and Tw Pmo replace balloon tests in diagnosing weakness cannot be recommended with constrength are shown. The curves demonstrate the empirical observation that the greatest fidence. Technical limitations might falsely label a few patients as weak, diverting the sensitivity and lowest false positive rate for confirming normal strength is achieved by com-clinician from the correct diagnosis. Furthermore, placement of balloon catheters probining Tw Pmo and Sn Pnas.
vides additional valuable physiological data in truly weak patients such as lung compliance and hemidiaphragm twitch Pdi. Patients with Discussion We conclude that Sn Pnas and Tw Pmo can diaphragm weakness are uncommon in clinical practice and it is therefore important to insatisfactorily exclude inspiratory muscle weakness in a substantial proportion of patients with vestigate them thoroughly and diagnose them accurately. Selecting out patients with low MIP suspected muscle weakness and a low MIP. Although very safe, the passage of balloon cath-and normal Sn Pnas or Tw Pmo will substantially reduce the numbers requiring balloon eters is mildly uncomfortable and requires the experience and expertise of a specialist laborat-tests which relatively few clinicians have immediately available. ory. By using these tests clinicians may be able to avoid tests with balloon catheters for a Although we have shown the benefit of Sn Pnas and Tw Pmo, especially when used tosignificant number of patients.
The validity of this approach rests on the gether, there are likely to be difficulties in adopting these tests, particularly Tw Pmo, as predefined limit values used for this study. The exclusion of muscle weakness after formal widely as MIP because of the cost and technical group.bmj.com on June 20, 2017 -Published by http://thorax.bmj.com/ Downloaded from
